We have shown previously that voluntary ethanol consumption and resistance to ethanol-induced sedation are inversely related to neuropeptide Y (NPY) levels in NPY-knock-out (NPY Ϫ/Ϫ ) and NPY-overexpressing mice. In the present report, we studied knock-out mice completely lacking the NPY Y1 receptor (Y1 Ϫ/Ϫ ) to further characterize the role of the NPY system in ethanol consumption and neurobiological responses to this drug. Here we report that male Y1 Ϫ/Ϫ mice showed increased consumption of solutions containing 3, 6, and 10% (v/v) ethanol when compared with wild-type (Y1 ϩ/ϩ ) control mice. Female Y1 Ϫ/Ϫ mice showed increased consumption of a 10% ethanol solution. In contrast, Y1 Ϫ/Ϫ mice showed normal consumption of solutions containing either sucrose or quinine.
Neuropeptide Y (NPY) is a 36 amino acid neurotransmitter that is widely distributed throughout the nervous system (Dumont et al., 1992; Colmer and Wahlestedt, 1993) . NPY has been implicated in the control of food intake (Clark et al., 1984; Levine and Morley, 1984) , cerebrocortical excitability (Woldbye et al., 1996 (Woldbye et al., , 1997 , cardiovascular homeostasis (Pedrazzini et al., 1998) , and in the integration of emotional behavior (Heilig et al., 1993; Heilig and Widerlov, 1995) . Recent evidence suggests that NPY is also involved with neurobiological responses to ethanol. Rats that were selectively bred for alcohol preference have altered levels of NPY in several brain regions compared with alcoholnonpreferring rats (Ehlers et al., 1998; Hwang et al., 1999) , and genetic linkage analysis of alcohol-preferring rats identified a chromosomal region that includes the NPY gene (Carr et al., 1998) . Voluntary ethanol consumption and resistance to the intoxicating effects of ethanol have been found to be inversely related to NPY levels in knock-out and transgenic mice (Thiele et al., 1998 (Thiele et al., , 2000a , central infusion of exogenous NPY has been shown to modulate ethanol drinking in rats (Badia-Elder et al., 2001a; Kelley et al., 2001) , and recent evidence indicates that the NPY system may modulate ethanol consumption and seizure during withdrawal from ethanol in humans (Kauhanen et al., 2000; Ilveskoski et al., 2001; Okubo and Harada, 2001 ). However, the NPY receptor(s) that mediate neurobiological responses to ethanol and ethanol consumption have not been clearly identified.
In the mouse, NPY acts through at least five receptor subtypes, namely the Y1, Y2, Y4, Y5, and Y6 receptors, all of which couple to heterotrimeric G-proteins that inhibit production of cAMP . The Y1 receptor has been identified in several brain regions that are involved with neurobiological responses to ethanol, including the hippocampus, the hypothalamus, and the amygdala (Ryabinin et al., 1997; Naveilhan et al., 1998) . Therefore, we studied alcohol consumption by Y1 Ϫ/Ϫ mice, which completely lack Y1 receptor expression as a result of targeted gene disruption (Pedrazzini et al., 1998) , and by normal Y1 ϩ/ϩ mice. Y1 Ϫ/Ϫ mice grow and reproduce at normal rates despite slightly diminished daily food intake and a reduced refeeding response to starvation. However, these animals develop late-onset obesity because of low energy expenditure (Pedrazzini et al., 1998) . We predicted that Y1 Ϫ/Ϫ mice would display ethanol-associated phenotypes similar to NPY Ϫ/Ϫ mice, and thus consume significantly more ethanol and show resistance to the intoxicating effects of ethanol relative to wild-type mice.
MATERIALS AND METHODS

Animals. Generation of the Y1
Ϫ/Ϫ mice has been described previously (Pedrazzini et al., 1998) . Starting with mice from the original population (Pedrazzini et al., 1998) 
, Y1
Ϫ/Ϫ mice were backcrossed for seven generations into a C57BL /6J background and were then bred with wild-type C57BL /6J mice to obtain heterozygote (Y1 ϩ/Ϫ ) knock-outs. Nonlittermate heterozygous mice were then bred, and F 2 mice from this cross yielded Y1 Ϫ/Ϫ mice and Y1 ϩ/ϩ mice. Littermate mice and their immediate offspring were used in the present studies. Each study described below used mice that were 8 -14 weeks of age, before the onset of obesity. Mice were individually housed in plastic mouse cages with ad libitum access to standard rodent chow (Teklad; Harlan, Madison, W I) and water throughout the experiments. The colony room was maintained at ϳ22°C with a 12 hr light /dark cycle. All procedures used in the present research were in compliance with National Institutes of Health guidelines, and the protocols were approved by the University of Washington Animal C are Committee.
Alcohol intak e test. Throughout the experiments, fluid intake, food intake, and body weight measures were assessed every 2 d. Y1
Ϫ/Ϫ mice (male, n ϭ 15; female, n ϭ 10) and Y1 ϩ/ϩ mice (male, n ϭ 11; female, n ϭ 12) were habituated in their home cage to drinking from two bottles containing plain water over 6 d. Mice were then given 24 hr access to two bottles, one containing plain water and the other containing ethanol in water. The concentration of ethanol (v/ v) was increased every 8 d; mice received 3%, 6%, and finally 10% ethanol over the course of the experiment. The positions of the bottles were changed every 2 d to control for position preferences. Average ethanol consumption per day was obtained for each ethanol concentration. To obtain a measure of ethanol consumption that corrected for individual differences in mouse size, grams of ethanol consumed per killigram of body weight per day were calculated for each mouse. As a measure of relative ethanol preference, an ethanol preference ratio was calculated at the 10% ethanol concentration by dividing total ethanol solution consumed by total fluid (ethanol plus water) consumption. T wo-way 2 ϫ 3 (genotype ϫ concentration) and 2 ϫ 4 (genotype ϫ trial) repeated-measures ANOVAs were used for statistical examination of the data.
Sucrose and quinine consumption test. Approximately 2 weeks after ethanol consumption testing, mice (same as above) were given plain water in one bottle and sucrose or quinine in the other bottle. The compounds were presented in the following order: sucrose solutions (1.70 and 4.25%) followed by quinine solutions (0.03 mM and 0.10 mM). Mice had 48 hr of access to each solution, and the position of the solution was counterbalanced between animals. Milliliters of solution consumed per killigram of body weight per day were calculated for each mouse. The data collected with each taste solution were analyzed separately with two-way 2 ϫ 2 (genotype ϫ concentration) repeated-measures ANOVAs.
Test for sensitivit y to ethanol-induced sedation. Naive male Y1 Ϫ/Ϫ (n ϭ 13) and Y1 ϩ/ϩ (n ϭ 11) mice were removed from their home cage and given an intraperitoneal injection of ethanol [3.5 gm / kg; 20% (w/ v) mixed in isotonic saline]. At the onset of ethanol-induced sedation, each mouse was placed on its back into a plastic U-shaped trough. The time (in minutes) that elapsed between the ethanol injection and when the mouse could right itself onto all four paws three times within a 30 sec interval was used as the index of time to regain the righting reflex. Approximately 2 weeks after the first injection, the same mice were again given an intraperitoneal injection of ethanol [4.0 gm / kg; 20% (w/ v) mixed in isotonic saline], and the time to regain the righting reflex was assessed. These data were analyzed with two-way 2 ϫ 2 (genotype ϫ concentration) repeated-measures ANOVAs.
Accelerating rotarod test. The rotarod test was used to assess sensitivity to drug-induced motor incoordination (herein referred to as ataxia) with naive mice. The rotarod apparatus (Ugo Basile Biological Research, Varese, Italy) consisted of a 3 cm diameter horizontal rotating rod divided into five 6 cm sections by tan acrylic disks. The rod was rotated by a motor that accelerated from 4 to 40 rpm over the course of 5 min. For each trial, the mouse was placed on the stationary rod, which was then rotated until the mouse fell. On days 1-3, mice were given three practice trials separated by 1 min. On days 4 -5, mice were given two practice trials, and then a third trial that was immediately preceded by an intraperitoneal injection of saline to habituate them to the injection procedures. On day 6, mice were given two practice trails. The third trial served as the critical test and was preceded by an intraperitoneal injection of ethanol [2.5 gm / kg; 20% (w/ v) mixed in isotonic saline]. Latency to fall (in seconds) on the test trial was recorded as the measure of sensitivity to ethanol-induced ataxia.
Plasma ethanol concentrations. Male Y1
Ϫ/Ϫ (n ϭ 12) and Y1 ϩ/ϩ (n ϭ 11) mice were given an intraperitoneal injection of ethanol [3.5 gm / kg; 20% (w/ v) mixed in isotonic saline; the same low-dose concentration used during sedation testing] and immediately returned to their home cages. At 1 hr after ethanol injection, one-half of the mice were rapidly anesthetized with C O 2 and decapitated for blood collection. The remaining mice were anesthetized and decapitated 3 hr after ethanol injection. Plasma ethanol levels were determined via spectrophotometic methods (Enzymatic Determination of Alcohol Test; Sigma, St. L ouis, MO) and calculated as milligrams per deciliter. A two-way 2 ϫ 2 (genotype ϫ time) multifactor ANOVA was used to analyze the data.
RESULTS
Alcohol, sucrose, and quinine consumption tests
The male Y1 Ϫ/Ϫ mice consumed significantly more of each ethanol solution than Y1 ϩ/ϩ control mice (Fig. 1a,b) . We expressed consumption of 10% ethanol relative to total fluid consumption (ethanol preference ratio). Both Y1 Ϫ/Ϫ and Y1 ϩ/ϩ mice preferred ethanol to water (preference ratios of Ͼ0.50), a behavior that is characteristic of C57BL /6 mice (Belknap et al., 1993) . Strikingly, despite this high basal consumption of ethanol by wild-type mice, Y1
Ϫ/Ϫ mice still showed increased ethanol consumption (Fig. 1c ). There were no significant differences between male Y1
Ϫ/Ϫ and Y1
ϩ/ϩ mice, nor were there differences over time, in measures of average body weight (Y1 Ϫ/Ϫ mice, 26.0 Ϯ 0.3 gm; Y1 ϩ/ϩ mice, 26.5 Ϯ 0.6 gm), average food intake (Y1
during the alcohol consumption test. To determine whether the Y1 Ϫ/Ϫ mice exhibited general differences in taste preference or consumption of solutions containing calories, we tested male mice with sucrose (a caloric compound) and quinine solutions, using the same protocol as above. We used these tastants because previous research has indicated that rodents perceive the taste of alcohol as a sweet-bitter compound (K iefer et al., 1990) . There were no significant differences between the genotypes in consumption of either sucrose or quinine solutions (Fig. 1d) . Thus, increased consumption of alcohol by male Y1 Ϫ/Ϫ mice does not appear to be associated with altered taste preference or caloric need.
Female Y1 Ϫ/Ϫ and Y1 ϩ/ϩ mice were also tested for consumption of ethanol solutions. Female Y1 Ϫ/Ϫ mice consumed significantly more of the 10% ethanol solution (Fig. 2a-c) , but unlike male Y1 Ϫ/Ϫ mice, they did not show significant altered consumption of the 3 and 6% ethanol solutions, suggesting a possible interaction between gender and expression of phenotypes associated with the gene mutation. However, similar to the male mice, increased consumption of the 10% ethanol solution by female Y1 Ϫ/Ϫ mice was impressive given the already high level of ethanol consumption by wild-type mice. During ethanol consumption testing, the female Y1 Ϫ/Ϫ and Y1 ϩ/ϩ mice did not differ in measures of average body weight (Y1 Ϫ/Ϫ mice, 22.4 Ϯ 1.0 gm; Y1 ϩ/ϩ mice, 22.7 Ϯ 0.5 gm) or average water consumption (Y1 Ϫ/Ϫ mice, 82.8 Ϯ 13.6 ml ⅐ kg
. Furthermore, female Y1 Ϫ/Ϫ mice did not show altered consumption of solutions containing either sucrose or quinine (Fig. 2d) .
Ethanol-induced sedation test and plasma ethanol levels
NPY
Ϫ/Ϫ mice showed reduced sensitivity to ethanol-induced sedation (Thiele et al., 1998) . Therefore, we sought to determine whether Y1 Ϫ/Ϫ mice were resistant to the sedative effects of ethanol. We used male mice because they showed increased consumption of each ethanol solution tested. Male Y1 Ϫ/Ϫ mice were resistant to the sedative effects of ethanol, regaining their righting reflex sooner than Y1 ϩ/ϩ mice after injection of both the 3.5 and 4.0 gm/kg ethanol doses (Fig. 3a) . Furthermore, differences in sensitivity to the sedative effects of ethanol (and ethanol consumption) do not appear to be secondary to differences in acute clearance of ethanol, because plasma ethanol concentrations at 1 and 3 hr after ethanol administration did not differ between the genotypes (Fig. 3b) .
Accelerating rotarod test
It has been suggested previously that multiple assessment tools should be used when studying knock-out mice to avoid misinterpretation of gene function (Boehm et al., 2000) . Therefore, we determined whether male Y1 Ϫ/Ϫ mice also showed reduced sensitivity to ethanol-induced motor impairment with the accelerating rotarod test, a common measure of drug-induced ataxia. Relative to wild-type mice, Y1 Ϫ/Ϫ mice did not differ in latency to fall from an accelerating rotarod immediately after injection of a 2.5 gm/kg dose of ethanol (Fig. 3c) .
DISCUSSION
Here we provide evidence suggesting that the NPY Y1 receptor regulates voluntary alcohol consumption and some of the acute intoxicating effects caused by administration of this drug. The high level of alcohol consumption by Y1 Ϫ/Ϫ mice does not appear to be related to the taste and/or caloric properties of ethanol, because the Y1 Ϫ/Ϫ mice showed normal consumption of solutions containing either sucrose or quinine and normal food intake.
Furthermore, resistance to ethanol-induced sedation (and high ethanol consumption) are not likely related to high ethanol metabolism, because the Y1 Ϫ/Ϫ mice showed normal plasma ethanol levels. Interestingly, Y1
Ϫ/Ϫ mice showed normal ethanol-induced ataxia on the rotarod test, suggesting that resistance to the neurobiological effects of ethanol in the Y1 Ϫ/Ϫ mice may be task-dependent, an observation that has been made with another mutant mouse model (Boehm et al., 2000) . Alternatively, it is possible that the 2.5 gm/kg ethanol dose used for the rotarod test may have been too high, thus producing a ceiling effect that prevented the detection of significant differences between the genotypes.
In the brain, NPY acts through Y1, Y2, and Y5 receptors, all of which couple to heterotrimeric G-proteins that inhibit production of cAMP (Heilig and Widerlov, 1995; Gerald et al., 1996) . The Y1 and Y5 receptors have been identified as postsynaptic (Michel, 1991; Naveilhan et al., 1998) , whereas the Y2 receptor appears to be a presynaptic autoreceptor that inhibits synaptic release of NPY (Chen et al., 1997) . The present results with Y1 Ϫ/Ϫ mice are consistent with those obtained with NPY Ϫ/Ϫ mice (Thiele et al., 1998) and suggest that the actions of NPY on voluntary ethanol consumption and ethanol-induced sedation are modulated by postsynaptic Y1 receptor signaling. Given the postsynaptic location of the Y5 receptor, one might also predict that Y5 receptor knock-out (Y5 Ϫ/Ϫ ) mice would show increased ethanol consumption. However, we have found previously that Y5 Ϫ/Ϫ mice showed normal consumption of solutions containing ethanol (Thiele et al., 2000a) . Together, the data suggest that ethanol consumption is modulated by the Y1 receptor, whereas other NPY receptors may not be involved. Because ethanol has calories, it is possible that the Y1 receptor modulates alcohol intake via the same hypothalamic system thought to stimulate feeding behavior . However, this does not seem likely, because Y1 Ϫ/Ϫ mice drank more ethanol solution yet had normal to reduced daily food intake (Pedrazzini et al., 1998) and did not show altered consumption of the caloric sucrose solution in the present study. Alternatively, there is increasing evidence from both human and animal research indicating that resistance to the intoxicating effects of ethanol is often associated with high levels of ethanol drinking (Schuckit, 1986 (Schuckit, , 1988 (Schuckit, , 1994 Thiele et al., 1998 Thiele et al., , 2000b Hodge et al., 1999) . One possible physiological role for the Y1 receptor may be to promote some of the intoxicating effects of ethanol, perhaps as a mechanism to limit alcohol intake. As such, a lack of Y1 receptor signaling would cause a resistance to the intoxicating effects of ethanol, thus eliminating this protective system and increasing the risk for high alcohol intake. Consistent with this hypothesis is evidence showing that central infusion of NPY potentiated ethanol-induced sleep time in rats (Badia-Elder et al., 2001b) and evidence that Y1 receptor signaling modulates the sedative effects of sodium pentobarbital (Naveilhan et al., 2001) .
The Y1 receptor may modulate ethanol consumption by inhibiting cAMP production (Heilig and Widerlov, 1995; Gerald et al., 1996) . In fact, recent data provide direct evidence that cAMP and cAMP-dependent protein kinase A (PKA) signaling regulate neurobiological responses to ethanol. Mutant mice lacking the RII␤ subunit of PKA drank more ethanol and were resistant to ethanol-induced sedation despite normal plasma ethanol levels (Thiele et al., 2000b) . A similar pattern of results was found in mice with targeted disruption of the stimulatory G-protein Gs␣, whereas transgenic mice overexpressing Gs␣ in forebrain showed reduced ethanol sensitivity (Wand et al., 2001 ). Finally, inactivation of the Drosophila amnesiac gene, which encodes a secreted neuropeptide that stimulates cAMP production, rendered flies more sensitive to ethanol-induced sedation (Moore et al., 1998) . It will be important to determine whether Y1 Ϫ/Ϫ mice have altered levels of cAMP and/or PKA, and whether cAMP antagonists can "normalize" ethanol drinking in these mice.
Several examples in the literature indicate that ethanol consumption and resistance are inversely related to NPY signaling. Both the NPY Ϫ/Ϫ and Y1 Ϫ/Ϫ mice showed increased ethanol consumption and reduced sensitivity to ethanol-induced sedation, whereas NPY-overexpressing mice showed low ethanol consumption and increased ethanol-induced sleep time (Thiele et al., 1998) . Furthermore, both the Indiana alcohol-preferring and high alcohol drinking rats, which were selectively bred for high ethanol consumption, showed reduced NPY levels in the central nucleus of the amygdala (Ehlers et al., 1998; Hwang et al., 1999) , and central infusion of NPY was found to attenuate the high ethanol consumption but increase ethanol-induced sleep time in alcohol preferring rats (Badia-Elder et al., 2001a,b) . However, it has also been reported that central infusion of NPY either has no effect on ethanol drinking (Slawecki et al., 2000) or can increase ethanol consumption when infused directly into the paraventricular nucleus of the hypothalamus (Kelley et al., 2001 ). The latter example suggests that NPY may have brain region-specific effects on voluntary ethanol consumption.
It is noteworthy that the Y1 receptor has been shown to mediate the anti-anxiety actions of NPY (Heilig et al., 1993) . Ϫ/Ϫ mice drank significantly more 10% ethanol solution than female Y1 ϩ/ϩ mice, but there were no significant genotype differences during assessment of the 3 and 6% ethanol solutions. *p Ͻ 0.05.
Furthermore, both the P rats and the NPY Ϫ/Ϫ mice show high basal levels of anxiety-associated behaviors Thiele et al., 1998) . Thus, high ethanol consumption may be secondary to high levels of anxiety. It will be important to determine whether Y1 Ϫ/Ϫ mice show altered basal levels of anxiety, and whether there is a direct link between anxiety and alcohol consumption in these knock-out and selectively bred models.
In summary, we show here that the NPY Y1 receptor is important for regulating ethanol intake and sensitivity to the sedative effects of ethanol. Given the health and social problems related to alcohol dependence, central NPY Y1-mediated pathways that regulate ethanol consumption might represent attractive therapeutic targets for the treatment of alcohol use disorders. Figure 3 . Tests of ethanol-induced intoxication and assessment of plasma ethanol levels with male Y1 Ϫ/Ϫ and Y1 ϩ/ϩ mice. a, The time that elapsed between intraperitoneal injection of ethanol [3.5 or 4.0 gm/kg; 20% (w/v) mixed in isotonic saline] and when the mouse could right itself onto all four paws three times within a 30 sec interval was used as the index of latency to right (in minutes). b, Plasma ethanol levels (in milliliters per deciliter) 1 or 3 hr after intraperitoneal injection of ethanol [3.5 gm/kg; 20% (w/v) mixed in isotonic saline]. c, Latency to fall (in seconds) from the rotarod on the last trial of each test day. Mice were first habituated ( H ) to walking on the rotarod apparatus for 3 d. For the next 2 d, mice were given an intraperitoneal injection of saline (S1 and S2) before placement on the rotarod, and on the final day of the study ( E), mice were given an intraperitoneal injection of ethanol [2.5 gm/kg; 20% (w/v) mixed in isotonic saline] immediately before rotarod testing. All values are means Ϯ SEM. ANOVAs indicated that Y1 Ϫ/Ϫ mice recovered from ethanol-induced sedation significantly sooner than Y1 ϩ/ϩ mice. *p Ͻ 0.05.
